Literature DB >> 31691149

Transpulmonary thermodilution before and during veno-venous extra-corporeal membrane oxygenation ECMO: an observational study on a potential loss of indicator into the extra-corporeal circuit.

Alexander Herner1, Tobias Lahmer1, Ulrich Mayr1, Sebastian Rasch1, Jochen Schneider1, Roland M Schmid1, Wolfgang Huber2,3.   

Abstract

Haemodynamic monitoring before extra-corporeal membrane oxygenation (ECMO) might help to optimize the effectiveness of ECMO. However, there are concerns that pulmonary arterial and trans-pulmonary thermodilution (TPTD) might be confounded by a loss of indicator into the ECMO-circuit, resulting in an overestimation of volumetric parameters. Since there is a lack of data on indicator dilution techniques during ECMO, we compared TPTD-measurements before and during ECMO. TPTD-derived parameters before and after initiation of ECMO were compared in 14 intensive care unit-patients with veno-venous ECMO and TPTD-monitoring (PiCCO®). Eight patients had a jugular and six patients a femoral central venous catheter (CVC). Cardiac index, global end-diastolic volume index (GEDVI) and extra-vascular lung water index (EVLWI) before ECMO as well as the ECMO-flow were comparable in patients with jugular and femoral CVC. Pre-ECMO, cardiac index (CI) was not significantly different compared to values during ECMO (4.5 ± 1.7 vs. 4.4 ± 2.1 L/min/m2; p = 0.43). By contrast, GEDVI (791 ± 179 vs. 974 ± 384 mL/m2; p = 0.04) and EVLWI (21 ± 9 vs. 28 ± 11 mL/kg; p < 0.01) were higher during ECMO than before. Increases in GEDVI (36 ± 210 vs. 378 ± 247 mL/m2; p = 0.02) and EVLWI (3 ± 2 vs. 11 ± 8 mL/kg; p = 0.06) were substantially more pronounced in patients with femoral compared to jugular indicator injection. In multivariate analysis, femoral indicator injection was independently associated with larger increases in GEDVI (p < 0.01) and EVLWI (p = 0.04) during ECMO. However, CI and haemodynamic parameters not derived from TPTD, but from pulse contour analysis (systolic and diastolic arterial pressure, stroke volume variation and pulse pressure variation) were not affected by the start of ECMO. Our study demonstrates marked increases in GEDVI and EVLWI after the onset of ECMO. These increases were more pronounced for femoral compared to jugular indicator injection. CI and haemodynamic parameters not derived from TPTD were not affected by the extra-corporeal circuit.

Entities:  

Keywords:  Cardiac output; Extra-corporeal membrane oxygenation; Extra-vascular lung water index; Global end-diastolic volume index; Pulse contour analysis; Trans-pulmonary thermodilution

Year:  2019        PMID: 31691149     DOI: 10.1007/s10877-019-00398-6

Source DB:  PubMed          Journal:  J Clin Monit Comput        ISSN: 1387-1307            Impact factor:   2.502


  27 in total

1.  Influence of an extracorporeal lung assist system on transpulmonary thermodilution-derived variables.

Authors:  S G Sakka
Journal:  Br J Anaesth       Date:  2010-05       Impact factor: 9.166

2.  Extracorporeal Membrane Oxygenation for Severe Acute Respiratory Distress Syndrome.

Authors:  Alain Combes; David Hajage; Gilles Capellier; Alexandre Demoule; Sylvain Lavoué; Christophe Guervilly; Daniel Da Silva; Lara Zafrani; Patrice Tirot; Benoit Veber; Eric Maury; Bruno Levy; Yves Cohen; Christian Richard; Pierre Kalfon; Lila Bouadma; Hossein Mehdaoui; Gaëtan Beduneau; Guillaume Lebreton; Laurent Brochard; Niall D Ferguson; Eddy Fan; Arthur S Slutsky; Daniel Brodie; Alain Mercat
Journal:  N Engl J Med       Date:  2018-05-24       Impact factor: 91.245

3.  [Temporary sterilization of heifers with gestagens. II].

Authors:  K Arbeiter; H K Dreier; H Spadiut; A Schwaighofer; J Fanta; O Straub
Journal:  Wien Tierarztl Monatsschr       Date:  1973-04       Impact factor: 0.348

4.  Secondary urinary reconstruction: use of the ileocecal segment.

Authors:  D G Skinner
Journal:  J Urol       Date:  1974-07       Impact factor: 7.450

5.  Thermodilution cardiac output may be incorrect in patients on venovenous extracorporeal lung assist.

Authors:  M Haller; C Zöllner; W Manert; J Briegel; E Kilger; J Polasek; T Hummel; H Forst; K Peter
Journal:  Am J Respir Crit Care Med       Date:  1995-12       Impact factor: 21.405

6.  Cardiac output: a central issue in patients with respiratory extracorporeal support.

Authors:  Stefano Romagnoli; Giovanni Zagli; Zaccaria Ricci; Gianluca Villa; Francesco Barbani; Fulvio Pinelli; Raffaele De Gaudio; Cosimo Chelazzi
Journal:  Perfusion       Date:  2016-07-20       Impact factor: 1.972

7.  Efficacy and economic assessment of conventional ventilatory support versus extracorporeal membrane oxygenation for severe adult respiratory failure (CESAR): a multicentre randomised controlled trial.

Authors:  Giles J Peek; Miranda Mugford; Ravindranath Tiruvoipati; Andrew Wilson; Elizabeth Allen; Mariamma M Thalanany; Clare L Hibbert; Ann Truesdale; Felicity Clemens; Nicola Cooper; Richard K Firmin; Diana Elbourne
Journal:  Lancet       Date:  2009-09-15       Impact factor: 79.321

8.  Extravascular lung water is an independent prognostic factor in patients with acute respiratory distress syndrome.

Authors:  Mathieu Jozwiak; Serena Silva; Romain Persichini; Nadia Anguel; David Osman; Christian Richard; Jean-Louis Teboul; Xavier Monnet
Journal:  Crit Care Med       Date:  2013-02       Impact factor: 7.598

9.  Fluid management in critically ill patients: the role of extravascular lung water, abdominal hypertension, capillary leak, and fluid balance.

Authors:  Colin Cordemans; Inneke De Laet; Niels Van Regenmortel; Karen Schoonheydt; Hilde Dits; Wolfgang Huber; Manu Lng Malbrain
Journal:  Ann Intensive Care       Date:  2012-07-05       Impact factor: 6.925

10.  Aiming for a negative fluid balance in patients with acute lung injury and increased intra-abdominal pressure: a pilot study looking at the effects of PAL-treatment.

Authors:  Colin Cordemans; Inneke De Laet; Niels Van Regenmortel; Karen Schoonheydt; Hilde Dits; Greg Martin; Wolfgang Huber; Manu Lng Malbrain
Journal:  Ann Intensive Care       Date:  2012-07-05       Impact factor: 6.925

View more
  6 in total

1.  Radiographic assessment of lung edema (RALE) score is associated with clinical outcomes in patients with refractory cardiogenic shock and refractory cardiac arrest after percutaneous implantation of extracorporeal life support.

Authors:  Ingo Voigt; Marco Mighali; Daniela Manda; Phillip Aurich; Oliver Bruder
Journal:  Intern Emerg Med       Date:  2022-02-15       Impact factor: 5.472

2.  Transpulmonary thermodilution in patients treated with veno-venous extracorporeal membrane oxygenation.

Authors:  Gregor Loosen; Alice Marguerite Conrad; Michael Hagman; Nils Essert; Manfred Thiel; Thomas Luecke; Joerg Krebs
Journal:  Ann Intensive Care       Date:  2021-07-02       Impact factor: 6.925

3.  CRRT influences PICCO measurements in febrile critically ill patients.

Authors:  Qiancheng Xu; Yuhan Cao; Weihua Lu; Jianguo Li
Journal:  Open Med (Wars)       Date:  2022-02-14

4.  Veno-Venous Extracorporeal Membrane Oxygenation in Minipigs as a Robust Tool to Model Acute Kidney Injury: Technical Notes and Characteristics.

Authors:  Antal Szabó-Biczók; Gabriella Varga; Zoltán Varga; Gábor Bari; Gyöngyvér Vigyikán; Ámos Gajda; Noémi Vida; Ádám Hodoniczki; Attila Rutai; László Juhász; Anna Nászai; Máté Gyöngyösi; Sándor Turkevi-Nagy; Dániel Érces; Mihály Boros
Journal:  Front Med (Lausanne)       Date:  2022-04-28

Review 5.  What is new in hemodynamic monitoring and management?

Authors:  Moritz Flick; Alina Bergholz; Pawel Sierzputowski; Simon T Vistisen; Bernd Saugel
Journal:  J Clin Monit Comput       Date:  2022-04-08       Impact factor: 1.977

6.  Increased extravascular lung water index (EVLWI) reflects rapid non-cardiogenic oedema and mortality in COVID-19 associated ARDS.

Authors:  Tobias Lahmer; Wolfgang Huber; Sebastian Rasch; Paul Schmidle; Sengül Sancak; Alexander Herner; Christina Huberle; Dominik Schulz; Ulrich Mayr; Jochen Schneider; Christoph D Spinner; Fabian Geisler; Roland M Schmid
Journal:  Sci Rep       Date:  2021-06-01       Impact factor: 4.379

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.